While dosing is the most significant determinant, other psychological and pharmacological factors also play a critical role. A positive mood before drug intake was strongly linked to elevated ratings ...

This article was originally published on Psychedelic Spotlight and appears here with permission. New study suggests that a non-hallucinogenic LSD analog may hold therapeutic potential for mood ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

Share on Pinterest The use of psychedelic drugs such as LSD in mental health treatment is at the forefront of clinical research. Lyuba Burakova/Stocksy Psychedelic compounds have gained increased ...

Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety Disorders Specifically, the Phase 1 study measured LSD dose-dependently induced subjective responses starting at ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. Lysergic acid ...